Bronchiectasis 2012 Prof. Dr. Bülent KARADAĞ

62
Bronchiectasis 2012 Prof. Dr. Bülent KARADAĞ Marmara Uni. Division of Paediatric Pulmonology

description

Bronchiectasis 2012 Prof. Dr. Bülent KARADAĞ Marmara Uni. Division of Paediatric Pulmonology. Bronchiectasis , children. 2305 articles 2013: 16 2012: 99 Turkey: 71 ( 3). Childhood Pneumonectomies: Two Decades' Experience of a Referral Center. - PowerPoint PPT Presentation

Transcript of Bronchiectasis 2012 Prof. Dr. Bülent KARADAĞ

Page 1: Bronchiectasis 2012                          Prof. Dr. Bülent KARADAĞ

Bronchiectasis 2012

Prof. Dr. Bülent KARADAĞ

Marmara Uni. Division of Paediatric

Pulmonology

Page 2: Bronchiectasis 2012                          Prof. Dr. Bülent KARADAĞ
Page 3: Bronchiectasis 2012                          Prof. Dr. Bülent KARADAĞ

Bronchiectasis, children

• 2305 articles

• 2013: 16

• 2012: 99

• Turkey: 71 ( 3) .

Page 4: Bronchiectasis 2012                          Prof. Dr. Bülent KARADAĞ

Childhood Pneumonectomies: Two Decades' Experience of a

Referral Center.

Yalcin S, Ciftci A, Karnak I, Ekinci S, Tanyel FC, Senocak M.

Eur J Pediatr Surg. 2012 Aug 17. .

Different features of lung involvement in Niemann-Pick disease

and Gaucher disease.

Gülhan B, Ozçelik U, Gürakan F, Güçer S, Orhan D, Cinel G,

Yalçin E, Ersöz DD, Kiper N, Yüce A, Kale G.

Respir Med. 2012 Sep;106(9):1278-85.

Surgical treatment of right middle lobe syndrome in children.

Sehitogullari A, Sayir F, Cobanoglu U, Bilici S.

Ann Thorac Med. 2012 Jan;7(1):8-11.

Page 5: Bronchiectasis 2012                          Prof. Dr. Bülent KARADAĞ

Bronchiectasis

1. PCD Diagnosis-Treatment2. PCD Genetics3. PCD LFT4. BE Diagnosis5. BE Etiology 6. BE Disease burden7. BE Surgery

Page 6: Bronchiectasis 2012                          Prof. Dr. Bülent KARADAĞ

6th February- Diamond Year of Queen Elisabeth

Page 7: Bronchiectasis 2012                          Prof. Dr. Bülent KARADAĞ

ERS Task Force26 countries, 194 centresPt per center : 4 (2-9)90% nasal/mucosal biopsy77% electron microscopy, 57% cilairy function testsNasal NO 46%, Saccharine 36%Variable management

Page 8: Bronchiectasis 2012                          Prof. Dr. Bülent KARADAĞ
Page 9: Bronchiectasis 2012                          Prof. Dr. Bülent KARADAĞ

Arab Spring-27th February

Page 10: Bronchiectasis 2012                          Prof. Dr. Bülent KARADAĞ

PCD Genetics

Exome sequencing for CCDC114 mutationsKnowles MR, Am J Hum Genet. 2013;10;92. Mutations causing PCD in 14 genes (60%)Sequence analysis in 6 probands on the ODA Chlamydomonas reinhardtii motility gene (DNAI2, DNAH5)

Page 11: Bronchiectasis 2012                          Prof. Dr. Bülent KARADAĞ

PCD Genetics

HEATR2 mutation Am J Hum Genet.

2012;91:685. Horani A

Amish community

OR, previously undefined

İmmunohistochemistry: HEATR2 in

cytoplasm, not in cilia.

Its role in the dynein arm transport?

Page 12: Bronchiectasis 2012                          Prof. Dr. Bülent KARADAĞ

PCD Genetics

Mata M, Am J Rhinol Allergy 2012;26:260.

Adenylate kinase 7 (AK7) mutation.

Mutations described in 5 genes.

Gene causing PCD?

Lower levels of AK7 gene expression

2 mutations described in AK7 gene

Page 13: Bronchiectasis 2012                          Prof. Dr. Bülent KARADAĞ

CCDC114 = ODA microtubule-docking complex

Page 14: Bronchiectasis 2012                          Prof. Dr. Bülent KARADAĞ
Page 15: Bronchiectasis 2012                          Prof. Dr. Bülent KARADAĞ
Page 16: Bronchiectasis 2012                          Prof. Dr. Bülent KARADAĞ

CCDC39,40 genes are related to IDA defects and

axonemal irregularity

Biallelic CCDC39 or

CCDC40 mutations

Patients with IDA defect

30/34 (%88.2)

Page 17: Bronchiectasis 2012                          Prof. Dr. Bülent KARADAĞ

Normal ciliary structure and lower levels of NOand PCD symptoms (DNAH11).163 ptsNormal structure=5823 indefinitive (17 situs inversus or BE, 6 lowNO) 13 pts with situs inversus… DNAH11 58pts with PCD 22% DNAH11

Page 18: Bronchiectasis 2012                          Prof. Dr. Bülent KARADAĞ

Munch- Scream (120 million

euro)

2nd May 2012

Page 19: Bronchiectasis 2012                          Prof. Dr. Bülent KARADAĞ

Shoemark A, J Clin Pathol

2012;65:267

20 years, 1182 pts

242 (20%) PCD

33 pts.. normal (3%)

Electron microscopy does not exclude the diagnosis!

Page 20: Bronchiectasis 2012                          Prof. Dr. Bülent KARADAĞ
Page 21: Bronchiectasis 2012                          Prof. Dr. Bülent KARADAĞ
Page 22: Bronchiectasis 2012                          Prof. Dr. Bülent KARADAĞ

ı

URT complicationsURT Sequelae follow-up ?OM with effusion and hearing loss do not recover after 9 years of age.Treatment increasing the mucociliary clearence ?

Page 23: Bronchiectasis 2012                          Prof. Dr. Bülent KARADAĞ

Spirometry or Plethysmography?

P. aeruginosa inf. 40% , BE 88 %

P. aeruginosa and BE (p=0.009; r=0.367) and air

trapping (p=0.03; r=0.315)

P. aeruginosa and RV >150% (p=0.04) and RV/TLC

>140% (p=0.001)

Page 24: Bronchiectasis 2012                          Prof. Dr. Bülent KARADAĞ

No correlation with P. aeruginosa infection and LFT

HRCT and RV (p=0.003; r=0.423), RV/TLC

(p<0.001; r =0.513)

Plethysmography >spirometry,

Page 25: Bronchiectasis 2012                          Prof. Dr. Bülent KARADAĞ
Page 26: Bronchiectasis 2012                          Prof. Dr. Bülent KARADAĞ
Page 27: Bronchiectasis 2012                          Prof. Dr. Bülent KARADAĞ
Page 28: Bronchiectasis 2012                          Prof. Dr. Bülent KARADAĞ
Page 29: Bronchiectasis 2012                          Prof. Dr. Bülent KARADAĞ

Spirometry ve progression of lung disease

20 pts comparison with HRCT (11.6 years)

Page 30: Bronchiectasis 2012                          Prof. Dr. Bülent KARADAĞ
Page 31: Bronchiectasis 2012                          Prof. Dr. Bülent KARADAĞ
Page 32: Bronchiectasis 2012                          Prof. Dr. Bülent KARADAĞ
Page 33: Bronchiectasis 2012                          Prof. Dr. Bülent KARADAĞ

<15 years,At least 8 years follow-up, 20 pts LFT worsens with ageCT scores increases with age, and inversely related with PaO2, FVC, FEV1,and FEF2575%.

Page 34: Bronchiectasis 2012                          Prof. Dr. Bülent KARADAĞ

2012 Summer Olympics

Page 35: Bronchiectasis 2012                          Prof. Dr. Bülent KARADAĞ

Multipl breath inert gas washout (MBW) test- Lung clearance index (LCI) reflects changes better.

LCI: PCD %85 abnormal Normal FEV1 %81 abnormalLCI is better correlated with other LFT parameters.

Page 36: Bronchiectasis 2012                          Prof. Dr. Bülent KARADAĞ

MR vs. HRCT

Page 37: Bronchiectasis 2012                          Prof. Dr. Bülent KARADAĞ
Page 38: Bronchiectasis 2012                          Prof. Dr. Bülent KARADAĞ
Page 39: Bronchiectasis 2012                          Prof. Dr. Bülent KARADAĞ

Swallowing and Endoscopy

66% BE (51% <2 yrs)

Severe norological sequelae (OR 9.45, P<0.004)

History of GER (OR 3.36, P=0.036)

Page 40: Bronchiectasis 2012                          Prof. Dr. Bülent KARADAĞ

77 (%68) +’ve BAL culture

49.5% Infection

%63 >1 pathogen

Age of diagnosis is important.

Page 41: Bronchiectasis 2012                          Prof. Dr. Bülent KARADAĞ
Page 42: Bronchiectasis 2012                          Prof. Dr. Bülent KARADAĞ
Page 43: Bronchiectasis 2012                          Prof. Dr. Bülent KARADAĞ

BE Infection

Hare KM, Int J Antimicrob Agents. 2012;40:365.

Long-term effects of antibiotics on nasopharyngeal

carrier status ?

AZT and β-lactam ab, 104 pts

Makrolide …Nazopharyngeal carrier status

decreases OR=0.2, (0.1-0.6)

β-lactam..OR=0.1, (0.1-0.3)

No effect on LRTI!

Rate of AB resistant m.o. increases !

Page 44: Bronchiectasis 2012                          Prof. Dr. Bülent KARADAĞ

BE Infection

Hare KM, Int J Antimicrob Agents. 2012; 40:365.

Makrolide:

Resistant S.pneumonia carrier: OR=4.5 (1.1-21.7)

Infection: OR=8.1, (1.4-81.3)

β-lactam ab:

Resistant H.influenza infection:OR=4.4 (0.8-23.9)

Long-term risks ?

Page 45: Bronchiectasis 2012                          Prof. Dr. Bülent KARADAĞ

Neutrophilia in BAL is correlated with culture but not

with PCR

Page 46: Bronchiectasis 2012                          Prof. Dr. Bülent KARADAĞ
Page 47: Bronchiectasis 2012                          Prof. Dr. Bülent KARADAĞ

BE Disease Burden

Kapur N, Chest 2012 Apr;141:1018-24.

Disease burden ?

QoL ve parental mental health and the effects of

exacerbations

Parent-proxy cough-specific quality of life [PC-QOL]

Depression, Anxiety, and Stress Scale [DASS])

Page 48: Bronchiectasis 2012                          Prof. Dr. Bülent KARADAĞ

BE Disease burden

Kapur N, Chest 2012 Apr;141:1018-24.

Stable state:

PC-QOL score:6.5 (5.3-6.9)

DASS 21 score: 6 (0-20).

Smaller age= worse QOL (P = .04)

Worsens with exacerbation

Page 49: Bronchiectasis 2012                          Prof. Dr. Bülent KARADAĞ

BE Disease Burden

Kapur N, Chest 2012 Apr;141:1018-24.

PC-QOL score (4.6 [3.8-5.4]; p= .001)

DASS score ( 22 [9-42]; P < .001)

Anxiety 38%, abnormal depression/stress 54%

Especially significant during exacerbations.

Prevention of BE, early diagnosis and treatment of

exacerbation may decrease the psychological

morbidity.

Page 50: Bronchiectasis 2012                          Prof. Dr. Bülent KARADAĞ

Whitney Houston (1963-2012)

Page 51: Bronchiectasis 2012                          Prof. Dr. Bülent KARADAĞ

Dave Brubeck, Ravi Shankar (1920-2012)

Page 52: Bronchiectasis 2012                          Prof. Dr. Bülent KARADAĞ
Page 53: Bronchiectasis 2012                          Prof. Dr. Bülent KARADAĞ

1.AO requiring intervention (2%)

2.BAL eosinophilia >%2.5, (34%)

3.BAL culture >104 CFU/ml (9%)

Required intervention in 23 pts.

Not only in localised BE, but for all on admission !

Page 54: Bronchiectasis 2012                          Prof. Dr. Bülent KARADAĞ

BE Definit,on of exacerbation

Wet cough and severe cough score in the last 3 days

are the best predictors.

Color of sputum, chest pain, dyspnea, haemoptysis

Adding CRP, amiloid-A and IL6 increases the specificity

and PPV.

Page 55: Bronchiectasis 2012                          Prof. Dr. Bülent KARADAĞ
Page 56: Bronchiectasis 2012                          Prof. Dr. Bülent KARADAĞ
Page 57: Bronchiectasis 2012                          Prof. Dr. Bülent KARADAĞ
Page 58: Bronchiectasis 2012                          Prof. Dr. Bülent KARADAĞ
Page 59: Bronchiectasis 2012                          Prof. Dr. Bülent KARADAĞ
Page 60: Bronchiectasis 2012                          Prof. Dr. Bülent KARADAĞ
Page 61: Bronchiectasis 2012                          Prof. Dr. Bülent KARADAĞ
Page 62: Bronchiectasis 2012                          Prof. Dr. Bülent KARADAĞ